KALA BIO, Inc. KALA
NASDAQ · United States · Health Technology
$0.4194-0.01 (-2.31%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q3 2025 | 2025-11-19 | -53.50 | -50.50 | -5.9% | -5.8%$34.45→$32.45 |
| Q2 2025 | 2025-08-08 | -65.94 | -102.00 | +35.4% | — |
| Q1 2025 | 2025-05-14 | -50.66 | -127.00 | +60.1% | — |
| Q4 2024 | 2025-03-31 | -61.58 | -123.50 | +50.1% | — |
| Q1 2024 | 2024-05-14 | -159.26 | -132.00 | -20.7% | — |
| Q4 2023 | 2024-03-29 | -79.07 | -200.00 | +60.5% | — |
| Q3 2023 | 2023-11-13 | -150.12 | 23.00 | -752.7% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.